Tarlatamab in small cell lung cancer (SCLC): Safety and efficacy analyzed by baseline brain metastasis
Champiat, S. Boyer, M. J. Govindan, R. Paz-Ares, L. G. Owonikoko, T. K. Borghaei, H. Izumi, H. Steeghs, N. Terbuch, A.
Champiat, S.
Boyer, M. J.
Govindan, R.
Paz-Ares, L. G.
Owonikoko, T. K.
Borghaei, H.
Izumi, H.
Steeghs, N.
Terbuch, A.
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Champiat S, Boyer MJ, Govindan R, Paz-Ares LG, Owonikoko TK, Borghaei H, et al. Tarlatamab in small cell lung cancer (SCLC): Safety and efficacy analyzed by baseline brain metastasis. Journal of Clinical Oncology. 2023 Jun;41(16). PubMed PMID: WOS:001053772003656.